Tharimmune (THAR): יתרות המזומנים של החברה

Tharimmune, Inc. (THAR) attracts leading antibody developers through scientific freedom and a flexible corporate culture. Business stability relies on R&D expense control and a secure capital reserve. The cash balance demonstrates current liquidity, where the 0.01 metric represents the current value. This supports the creation of unique therapies for the treatment of dermatological and hepatic pathologies.
פילוחי נתונים אנליטיים מרוכזים עבור Tharimmune Corp (THAR)

The innovative potential of Tharimmune, Inc. (THAR) in developing targeted antibodies requires colossal expenditures, making the cash balance a key indicator of the brand's financial viability. This metric measures the volume of liquid assets available to cover operating expenses and debts, allowing investors to assess default risk or the necessity of a secondary offering should capital turnover rates decline.